Savient Pharmaceuticals (SVNT) Posts Q2 Loss of 23c/Share
Tweet Send to a FriendGet Alerts SVNT Hot Sheet
Price: $0.56 -1.75%
EPS Growth %: +30.6%
Financial Fact:
Basic and diluted: -0.34
Today's EPS Names:
ANF, DXLG, FL, More
EPS Growth %: +30.6%
Financial Fact:
Basic and diluted: -0.34
Today's EPS Names:
ANF, DXLG, FL, More
Trade SVNT Now!
Savient Pharmaceuticals (NASDAQ: SVNT) reported Q2 EPS of ($0.23), $0.21 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $4.6 million versus the consensus estimate of $5.24 million.
For earnings history and earnings-related data on Savient Pharmaceuticals (SVNT) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Savient Pharmaceuticals (SVNT) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- UPDATE: 8x8 Inc. (EGHT) Misses Q4 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
